chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Anaesthetic complication, Cardiac arrest, Drug hypersensitivity, Flushing, Heart rate increased
Clinical narrative: On November 11, 2021 I was having surgery and had a more severe reaction to anesthesia that was more severe than normal.  I vomited a lot.  The antibiotic given after surgery was Keflex.  The symptoms began as itching on my hands and feet.  I felt flushed and my skin turned purple.  My heart rate was elevated.  I used a walker to go to the hall to get help from a nurse and woke up to CPR.  I had gone into cardiac arrest.  They noted that I was allergic to Keflex.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Resuscitation, Skin discolouration, Surgery, Vomiting
Clinical narrative: On November 11, 2021 I was having surgery and had a more severe reaction to anesthesia that was more severe than normal.  I vomited a lot.  The antibiotic given after surgery was Keflex.  The symptoms began as itching on my hands and feet.  I felt flushed and my skin turned purple.  My heart rate was elevated.  I used a walker to go to the hall to get help from a nurse and woke up to CPR.  I had gone into cardiac arrest.  They noted that I was allergic to Keflex.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Walking aid user
Clinical narrative: On November 11, 2021 I was having surgery and had a more severe reaction to anesthesia that was more severe than normal.  I vomited a lot.  The antibiotic given after surgery was Keflex.  The symptoms began as itching on my hands and feet.  I felt flushed and my skin turned purple.  My heart rate was elevated.  I used a walker to go to the hall to get help from a nurse and woke up to CPR.  I had gone into cardiac arrest.  They noted that I was allergic to Keflex.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Dyspnoea, Dyspnoea exertional, Glycosylated haemoglobin increased
Clinical narrative: Patient received moderna vaccine on 3/25/21 and 4/26/21. Patient presented to ER on 7/12/22. Found to be covid positive. admitted on 7/12/2022 for shortness of breath cough with green phlegm production, wheezing and dyspnea upon exertion               Known COPD.  Initially requiring 2 L oxygen.  COVID positive, vaccinated.  Managed with dexamethasone, nebulization, doxycycline             U tox positive for cocaine.  Metoprolol held.              Cardizem dose decreased.  Losartan added .  Clinically improved. maintaining saturation on room air.  Counseled to quit smoking and cocaine.             A1c 6.8, continue home insulin dose. No new concerns. Patient is medically stable to be discharge Home on 7/14/22.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough, SARS-CoV-2 test positive, Sputum discoloured, Toxicologic test abnormal, Wheezing
Clinical narrative: Patient received moderna vaccine on 3/25/21 and 4/26/21. Patient presented to ER on 7/12/22. Found to be covid positive. admitted on 7/12/2022 for shortness of breath cough with green phlegm production, wheezing and dyspnea upon exertion               Known COPD.  Initially requiring 2 L oxygen.  COVID positive, vaccinated.  Managed with dexamethasone, nebulization, doxycycline             U tox positive for cocaine.  Metoprolol held.              Cardizem dose decreased.  Losartan added .  Clinically improved. maintaining saturation on room air.  Counseled to quit smoking and cocaine.             A1c 6.8, continue home insulin dose. No new concerns. Patient is medically stable to be discharge Home on 7/14/22.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient was given expired vaccine well past the 30 day recommendation
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Influenza like illness, Pneumonitis, Pyrexia
Clinical narrative: Same evening I started to get chills, a fever, and starting to get shaking as well. Flu like symptoms and also shortness of breath. That stayed with me for a while and I called my telehealth line to ensure everything was okay. I feel like I waited about 48 hours after receiving the vaccine to ask my telehealth doctor. The fever broke the first day and the trouble breathing lingered for quite a few days. Doctor stated that it seemed that I was having inflammation of the lungs and I was prescribed a steroid to help with the inflammation and I did not end up taking it because it ended up clearing up well before the steroid was needed. It lasted for around two weeks and since then I have not had any types of reactions like this.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Same evening I started to get chills, a fever, and starting to get shaking as well. Flu like symptoms and also shortness of breath. That stayed with me for a while and I called my telehealth line to ensure everything was okay. I feel like I waited about 48 hours after receiving the vaccine to ask my telehealth doctor. The fever broke the first day and the trouble breathing lingered for quite a few days. Doctor stated that it seemed that I was having inflammation of the lungs and I was prescribed a steroid to help with the inflammation and I did not end up taking it because it ended up clearing up well before the steroid was needed. It lasted for around two weeks and since then I have not had any types of reactions like this.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: The patient was given an expired vaccine well past the 30 days recommendation. No s/s of and adverse  event at this time
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Dyspnoea, Dyspnoea exertional, Imaging procedure
Clinical narrative: Patient received moderna vaccine on 2/9/21, 3/11/21, and 12/6/21. Presented to ER on 7/12/22 and was positive on 7/12/22. He was tested for COVID at home by his wife and was positive.  He has no known other sick contacts.  Patient denies any chest pain.  While in the ER workup was essentially unremarkable however he states he feels short of breath when going up and down the stairs.  He has 17 steps to get into his house which she is unable to do currently.  He is saturating well on room air around 94%.  Chest imaging is unremarkable.  Lab work is unremarkable as well.  Patient will be admitted for overnight observation secondary to his severe weakness. No COVID specific treatments. Discharged on 7/15/22
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test normal, SARS-CoV-2 test positive
Clinical narrative: Patient received moderna vaccine on 2/9/21, 3/11/21, and 12/6/21. Presented to ER on 7/12/22 and was positive on 7/12/22. He was tested for COVID at home by his wife and was positive.  He has no known other sick contacts.  Patient denies any chest pain.  While in the ER workup was essentially unremarkable however he states he feels short of breath when going up and down the stairs.  He has 17 steps to get into his house which she is unable to do currently.  He is saturating well on room air around 94%.  Chest imaging is unremarkable.  Lab work is unremarkable as well.  Patient will be admitted for overnight observation secondary to his severe weakness. No COVID specific treatments. Discharged on 7/15/22
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Heart rate increased
Clinical narrative: Shortness of breath and accelarated heart rate. These two things happen only when I'm in bed and I'm about to fall asleep.   It started at the end of July 2021, every night, until the end of October 2021. Then It stopped for a while, but now it happens less often. It could be 1 or 2 nights in a row, every 3 weeks more or less. Last time this happens was the 3rd week of June 2022, and I had it for 3 nights in a row.
Age: 34.0
Sex: M
Vaccine: UNK
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Patient reports after vaccination developed marble sized bump at vaccination site that is tender to touch, pain has been improving but bump size remains stable per patient. Patient on vacation at time adverse event reported and advised to visit local urgent care. Patient may seek office/clinic visit upon return from vacation.
Age: 16.0
Sex: M
Vaccine: DTAPHEPBIP, HPV9, MMR, VARCEL
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old male give Pediarix which is for 7 year olds and younger.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Synovial cyst
Clinical narrative: Developed a pea size ganglion cyst in the left hand. My vaccine shot was always administered in my left arm.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: Pt was not old enough to receive 4th pfizer shot ** 2nd booster**
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Heart rate increased, Peripheral swelling, Pruritus
Clinical narrative: On June 14, 2022, I took 2 amoxicillin pills before my dentist's office visit for cleaning.  In the past I have never had a reaction to this antibiotic.  While driving to the dentist I began to have itching and burning in my hands.  I took a Benadryl.  Then it started in my feet.  I went to the pharmacy to get an EpiPen.  My heart rate was elevated.  They called 911.  EMT's  began administering medications to help and monitoring my heart.  I rode in the ambulance to the ER.  They gave me an IV with epinephrine.  My arms and legs were beginning to swell.  I did not go into cardiac arrest this time.  I stayed for a few hours and was monitored.  In essence, since first booster and second booster I have now become allergic to Keflex and Amoxicillin and it can cause cardiac arrest.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Medical Assistant correctly drew up 2.2 mL of normal saline to dilute the vial of vaccine. She then mistakenly administered 2.2 mL of vaccine (not 0.2 mL) to inoculate the patient.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dizziness, Loss of consciousness, SARS-CoV-2 test positive, Syncope
Clinical narrative: Patient received moderna vaccine on 2/9/21, 3/9/21, and 11/5/21. Presented to ER on 7/12/22 and found to be COVID positive. presents to ER after syncopal episode. She was in a meeting when she became woozy and passed out. There were some witnesses, no seizre like activity noted. Patient denies feeling palpiations or sob prior to the episode. She lost consciousness for a brief period. When she woke up she was not confused. Per the daughter, patient has had what sound like vasovagal episodes while giving blood in the past. Patient had a bout of emesis when she woke up as well. She denies current nausea, abd pain, cp, sob or focal neuro s/s. Admitted and not placed on any specific COVID19 treatments. Discharged on 7/14/22
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Patient received moderna vaccine on 2/9/21, 3/9/21, and 11/5/21. Presented to ER on 7/12/22 and found to be COVID positive. presents to ER after syncopal episode. She was in a meeting when she became woozy and passed out. There were some witnesses, no seizre like activity noted. Patient denies feeling palpiations or sob prior to the episode. She lost consciousness for a brief period. When she woke up she was not confused. Per the daughter, patient has had what sound like vasovagal episodes while giving blood in the past. Patient had a bout of emesis when she woke up as well. She denies current nausea, abd pain, cp, sob or focal neuro s/s. Admitted and not placed on any specific COVID19 treatments. Discharged on 7/14/22
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTERED VACCINE AFTER BEYOND USE DATE
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Palpitations, Pharyngeal swelling, Swelling face
Clinical narrative: Severe facial swelling for 24 hours, throat swelling for 24 hours. throat still swells from time to time for up to 24 hours, heart palpations that last for a few minutes that continue until this very day, Chest tightness that continues from time to time but doesn't persist.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood potassium increased, Blood urea increased, Brain natriuretic peptide, COVID-19
Clinical narrative: Patient received moderna vaccine on 3/16/21 and 4/13/21. Presented to ER on 7/14/22 and found to be covid positive. Evaluation in the ED did reveal a temperature of 97.9° initial pulse was 93 blood pressure 170/94 98% on room air, was placed on 2 L for comfort.  Incidentally her COVID was positive potassium 5.5 BUN creatinine of 75 and 12.90 INR 1.3 BNP 6-6 white count within normal limits at 5.31 H and H of 7.3/23.5 platelets of 164 x-ray of the chest did reveal cardiomegaly with interstitial pulmonary edema and small bilateral pleural effusions suggestive of volume overload. Patient was admitted. Received no specific COVID19 medications. Discharged on 7/18/22
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiomegaly, Chest X-ray abnormal, Haematocrit decreased, Haemoglobin decreased, Hypervolaemia
Clinical narrative: Patient received moderna vaccine on 3/16/21 and 4/13/21. Presented to ER on 7/14/22 and found to be covid positive. Evaluation in the ED did reveal a temperature of 97.9° initial pulse was 93 blood pressure 170/94 98% on room air, was placed on 2 L for comfort.  Incidentally her COVID was positive potassium 5.5 BUN creatinine of 75 and 12.90 INR 1.3 BNP 6-6 white count within normal limits at 5.31 H and H of 7.3/23.5 platelets of 164 x-ray of the chest did reveal cardiomegaly with interstitial pulmonary edema and small bilateral pleural effusions suggestive of volume overload. Patient was admitted. Received no specific COVID19 medications. Discharged on 7/18/22
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: International normalised ratio increased, Platelet count normal, Pleural effusion, Pulmonary oedema, SARS-CoV-2 test positive
Clinical narrative: Patient received moderna vaccine on 3/16/21 and 4/13/21. Presented to ER on 7/14/22 and found to be covid positive. Evaluation in the ED did reveal a temperature of 97.9° initial pulse was 93 blood pressure 170/94 98% on room air, was placed on 2 L for comfort.  Incidentally her COVID was positive potassium 5.5 BUN creatinine of 75 and 12.90 INR 1.3 BNP 6-6 white count within normal limits at 5.31 H and H of 7.3/23.5 platelets of 164 x-ray of the chest did reveal cardiomegaly with interstitial pulmonary edema and small bilateral pleural effusions suggestive of volume overload. Patient was admitted. Received no specific COVID19 medications. Discharged on 7/18/22
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count normal
Clinical narrative: Patient received moderna vaccine on 3/16/21 and 4/13/21. Presented to ER on 7/14/22 and found to be covid positive. Evaluation in the ED did reveal a temperature of 97.9° initial pulse was 93 blood pressure 170/94 98% on room air, was placed on 2 L for comfort.  Incidentally her COVID was positive potassium 5.5 BUN creatinine of 75 and 12.90 INR 1.3 BNP 6-6 white count within normal limits at 5.31 H and H of 7.3/23.5 platelets of 164 x-ray of the chest did reveal cardiomegaly with interstitial pulmonary edema and small bilateral pleural effusions suggestive of volume overload. Patient was admitted. Received no specific COVID19 medications. Discharged on 7/18/22
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Malaise, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I was asked to report as an adverse event that I tested positive for COVID on June 23, 2022.   My first symptom was on June 22, 2022.  I received a Paxlovid prescription from my health care provider (it was the weekend so I went through  virtual COVID triage). My symptoms were a scratch throat, runny nose, and cough.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: I was asked to report as an adverse event that I tested positive for COVID on June 23, 2022.   My first symptom was on June 22, 2022.  I received a Paxlovid prescription from my health care provider (it was the weekend so I went through  virtual COVID triage). My symptoms were a scratch throat, runny nose, and cough.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Medication pulled from freezer, dated with 70 day expiration date instead of 30 day.  Patient received medication that was expired by two days
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Covid vaccine 12plus given instead of 5-7 year dose.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, Chest X-ray abnormal, Confusional state, Diarrhoea
Clinical narrative: Patient received moderna vaccine on 1/29/21, 3/1/21, and 11/3/21. Presented to ER on 7/16/22 and found to be COVID positive. Presented to the ed for syncope found to be hypotensive. Patient was walking to her car when she began acting disoriented, confused and unsteady. Patients family was able to catch her before hitting the ground. Unconscious for seconds. Endorsing diarrhea for last couple of days. Family also reports that patient does not eat or drink well and has lost several pounds over last year due to anxiety and depression, which she sees her PCP for. Patient denies headache, chest pain, shortness of breath, abdominal pain, nausea, vomiting, dysuria.  COVID  - patient has diarrhea, but otherwise seems asymptomatic  - no indication for dexamethasone or remdesivir  - airborne and contact precautions  Discharged on 7/18/22
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Gait disturbance, Hypophagia, Hypotension, Loss of consciousness
Clinical narrative: Patient received moderna vaccine on 1/29/21, 3/1/21, and 11/3/21. Presented to ER on 7/16/22 and found to be COVID positive. Presented to the ed for syncope found to be hypotensive. Patient was walking to her car when she began acting disoriented, confused and unsteady. Patients family was able to catch her before hitting the ground. Unconscious for seconds. Endorsing diarrhea for last couple of days. Family also reports that patient does not eat or drink well and has lost several pounds over last year due to anxiety and depression, which she sees her PCP for. Patient denies headache, chest pain, shortness of breath, abdominal pain, nausea, vomiting, dysuria.  COVID  - patient has diarrhea, but otherwise seems asymptomatic  - no indication for dexamethasone or remdesivir  - airborne and contact precautions  Discharged on 7/18/22
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Syncope
Clinical narrative: Patient received moderna vaccine on 1/29/21, 3/1/21, and 11/3/21. Presented to ER on 7/16/22 and found to be COVID positive. Presented to the ed for syncope found to be hypotensive. Patient was walking to her car when she began acting disoriented, confused and unsteady. Patients family was able to catch her before hitting the ground. Unconscious for seconds. Endorsing diarrhea for last couple of days. Family also reports that patient does not eat or drink well and has lost several pounds over last year due to anxiety and depression, which she sees her PCP for. Patient denies headache, chest pain, shortness of breath, abdominal pain, nausea, vomiting, dysuria.  COVID  - patient has diarrhea, but otherwise seems asymptomatic  - no indication for dexamethasone or remdesivir  - airborne and contact precautions  Discharged on 7/18/22
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient had received 2 primary Moderna vaccines at a different facility in March 2021 and April 2021 at the age of 16 before Moderna was approved for patients 12 and older. Patient's guardian failed to provide us with the information on the error previously made by the other facility. When asked if patient wanted to stay with Moderna for their booster the guardian agreed to it and failed to mention any previous errors or problems with previous vaccination.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: No problem with the vaccine but on July 5, I started getting symptoms.  On July 7 I tested positive with a home test.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Feeling abnormal
Clinical narrative: I was in the city from 07/13/2022 to 07/16/2022. Around 09:00PM on 07/16 I had a headache. When I returned home, I also noticed a sore throat and I felt very fatigued and when I went to bed I had the chills. The next morning I felt off, I was still fatigued and the headache continued. I also began to feel a stuffy nose and congestion. I took an at home COVID-19 test the afternoon of 07/17 and it was positive. I immediately began to isolate from my husband. I called my doctor that Monday 07/18 who advised that I just treat my symptoms with over the counter medication. I've been taking Advil for my headache and throat lozenges for my sore throat. My symptoms have been improving and I would say that I am currently on 07/21/2022 at 90%. I still have some congestion and an occasional cough, but I feel pretty much better at this point.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nasal congestion, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I was in the city from 07/13/2022 to 07/16/2022. Around 09:00PM on 07/16 I had a headache. When I returned home, I also noticed a sore throat and I felt very fatigued and when I went to bed I had the chills. The next morning I felt off, I was still fatigued and the headache continued. I also began to feel a stuffy nose and congestion. I took an at home COVID-19 test the afternoon of 07/17 and it was positive. I immediately began to isolate from my husband. I called my doctor that Monday 07/18 who advised that I just treat my symptoms with over the counter medication. I've been taking Advil for my headache and throat lozenges for my sore throat. My symptoms have been improving and I would say that I am currently on 07/21/2022 at 90%. I still have some congestion and an occasional cough, but I feel pretty much better at this point.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Pulmonary congestion, Pyrexia
Clinical narrative: On Monday July 11, I began to experience a coughing problem. I didn't realize at the time, but I was exposed to someone who tested positive for COVID-19. I did not test myself until July 13 with an over the counter test which was positive. I developed congestion in my lungs and on Thursday I had a 101 fever. At that point when I tested positive, I contacted my physician but he was on vacation. The doctor who was covering prescribed PAXLOVID given my age, but since my health was in good condition, she recommended not to take it unless my symptoms got worse. My symptoms were getting better over the last few days, so I did not take PAXLOVID. I have had no fever for the past 2 days. I still have a cough and some congestion and a runny nose. Yesterday and today, I also tested myself again and I'm still testing positive. My wife on the other hand, took PAXLOVID a month ago and had relapsed COVID-19. I'm still testing positive, but my symptoms are getting better.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: On Monday July 11, I began to experience a coughing problem. I didn't realize at the time, but I was exposed to someone who tested positive for COVID-19. I did not test myself until July 13 with an over the counter test which was positive. I developed congestion in my lungs and on Thursday I had a 101 fever. At that point when I tested positive, I contacted my physician but he was on vacation. The doctor who was covering prescribed PAXLOVID given my age, but since my health was in good condition, she recommended not to take it unless my symptoms got worse. My symptoms were getting better over the last few days, so I did not take PAXLOVID. I have had no fever for the past 2 days. I still have a cough and some congestion and a runny nose. Yesterday and today, I also tested myself again and I'm still testing positive. My wife on the other hand, took PAXLOVID a month ago and had relapsed COVID-19. I'm still testing positive, but my symptoms are getting better.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTERED VACCINE AFTER BEYOND USE DATE
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Alanine aminotransferase increased, Aspartate aminotransferase increased, Atypical pneumonia
Clinical narrative: Patient received pfizer vaccine on 8/24/21 and 9/22/21. COVID positive on 7/1/22. PResented to ER on 7/7/22. COVID test + about 7 days ago and was treated with Paxlovid and 2 L of oxygen and dexamethasone at NH. He went to Hospital ED because his respiratory status get worse with hypoxia and then required intubation. He was also found to be hypotensive and required pressor therapy.  He was then transferred for further care. patient's diagnosed and admitted as septic shock with acute hypoxic respiratory failure with COVID-19 pneumonia, hypernatremia, AKI, elevated transaminitis, Troponin. ICU, cardiologist, nephrologist, id is consulted. Patient received amiodarone drip for non sustained V-tach and then switched to oral Amiodarone. TTE showed stage 1 multiple segmental abnormalities.  No mention of EF and no pericardial effusion. Cardiologist requested records to see if findings are new.  Pt previously on meds for heart failure.  No further ischemic workup pursued given pt's comorbidities and acute illness. Pt to f/u with Cardiologist as OP and ischemic workup can be considered.  Initially patient require Levophed for septic shock, blood pressure is improved and levophed is off since 7/7/22 overnight    COVID 19 +,  WBC 23, Elevated inflammatory markers- D-dimer > 20, AST 680, ALT 496, troponin 557, BNP 460, C-reactive protein 200, procalcitonin 84, Inflammatory markers are improved.  patient was treated with cefepime, Flagyl, Decadron, Hydrocort, Remdesivir. oxygen saturation was improved and then patient is extubated on  07/11/2022,    MRSA nasal +. respiratory culture- MRSA, extended spectrum cephalosporin resistant Klebsiella pneumonia, continue Abx as per ID,  Initially cefepime and Flagyl and then switched to vancomycin meropenem which is completed.   sodium was 152 and improved, creatinine 2.4 and improved, and nephrology is consulted and appreciate recommendation. Electrolytes are replaced. Foley was placed initially for I/O but patient failed voiding trial and need to reinsert foley. Patient need to follow in urology clinic.   Imagings CXR- Patch like areas of opacification in the mid and lower lungs may be infectious/inflammatory in etiology.  Aspiration could be considered,  V/Q scan- Low probability for pulmonary embolus.   CT chest- Extensive changes of multifocal atypical pneumonia most confluent at the left greater than right lower lobes, with all lobes involved.Severe appearing changes of coronary artery disease are present.   CT abd Suspected colitis most likely infectious. Foley catheter is seen within the urinary bladder which is collapsed and thick-walled. Duplex no DVT, renal US- no acute changes Echo- Stage 1: 1: Multiple segmental abnormalities exist. See findings. Definity contrast agent was given IV to delineate the left ventricular endocardial borders. Discharged on 7/20/22
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder catheterisation, Bladder hypertrophy, Blood creatinine increased, Blood pressure abnormal, Blood sodium increased
Clinical narrative: Patient received pfizer vaccine on 8/24/21 and 9/22/21. COVID positive on 7/1/22. PResented to ER on 7/7/22. COVID test + about 7 days ago and was treated with Paxlovid and 2 L of oxygen and dexamethasone at NH. He went to Hospital ED because his respiratory status get worse with hypoxia and then required intubation. He was also found to be hypotensive and required pressor therapy.  He was then transferred for further care. patient's diagnosed and admitted as septic shock with acute hypoxic respiratory failure with COVID-19 pneumonia, hypernatremia, AKI, elevated transaminitis, Troponin. ICU, cardiologist, nephrologist, id is consulted. Patient received amiodarone drip for non sustained V-tach and then switched to oral Amiodarone. TTE showed stage 1 multiple segmental abnormalities.  No mention of EF and no pericardial effusion. Cardiologist requested records to see if findings are new.  Pt previously on meds for heart failure.  No further ischemic workup pursued given pt's comorbidities and acute illness. Pt to f/u with Cardiologist as OP and ischemic workup can be considered.  Initially patient require Levophed for septic shock, blood pressure is improved and levophed is off since 7/7/22 overnight    COVID 19 +,  WBC 23, Elevated inflammatory markers- D-dimer > 20, AST 680, ALT 496, troponin 557, BNP 460, C-reactive protein 200, procalcitonin 84, Inflammatory markers are improved.  patient was treated with cefepime, Flagyl, Decadron, Hydrocort, Remdesivir. oxygen saturation was improved and then patient is extubated on  07/11/2022,    MRSA nasal +. respiratory culture- MRSA, extended spectrum cephalosporin resistant Klebsiella pneumonia, continue Abx as per ID,  Initially cefepime and Flagyl and then switched to vancomycin meropenem which is completed.   sodium was 152 and improved, creatinine 2.4 and improved, and nephrology is consulted and appreciate recommendation. Electrolytes are replaced. Foley was placed initially for I/O but patient failed voiding trial and need to reinsert foley. Patient need to follow in urology clinic.   Imagings CXR- Patch like areas of opacification in the mid and lower lungs may be infectious/inflammatory in etiology.  Aspiration could be considered,  V/Q scan- Low probability for pulmonary embolus.   CT chest- Extensive changes of multifocal atypical pneumonia most confluent at the left greater than right lower lobes, with all lobes involved.Severe appearing changes of coronary artery disease are present.   CT abd Suspected colitis most likely infectious. Foley catheter is seen within the urinary bladder which is collapsed and thick-walled. Duplex no DVT, renal US- no acute changes Echo- Stage 1: 1: Multiple segmental abnormalities exist. See findings. Definity contrast agent was given IV to delineate the left ventricular endocardial borders. Discharged on 7/20/22
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Patient received pfizer vaccine on 8/24/21 and 9/22/21. COVID positive on 7/1/22. PResented to ER on 7/7/22. COVID test + about 7 days ago and was treated with Paxlovid and 2 L of oxygen and dexamethasone at NH. He went to Hospital ED because his respiratory status get worse with hypoxia and then required intubation. He was also found to be hypotensive and required pressor therapy.  He was then transferred for further care. patient's diagnosed and admitted as septic shock with acute hypoxic respiratory failure with COVID-19 pneumonia, hypernatremia, AKI, elevated transaminitis, Troponin. ICU, cardiologist, nephrologist, id is consulted. Patient received amiodarone drip for non sustained V-tach and then switched to oral Amiodarone. TTE showed stage 1 multiple segmental abnormalities.  No mention of EF and no pericardial effusion. Cardiologist requested records to see if findings are new.  Pt previously on meds for heart failure.  No further ischemic workup pursued given pt's comorbidities and acute illness. Pt to f/u with Cardiologist as OP and ischemic workup can be considered.  Initially patient require Levophed for septic shock, blood pressure is improved and levophed is off since 7/7/22 overnight    COVID 19 +,  WBC 23, Elevated inflammatory markers- D-dimer > 20, AST 680, ALT 496, troponin 557, BNP 460, C-reactive protein 200, procalcitonin 84, Inflammatory markers are improved.  patient was treated with cefepime, Flagyl, Decadron, Hydrocort, Remdesivir. oxygen saturation was improved and then patient is extubated on  07/11/2022,    MRSA nasal +. respiratory culture- MRSA, extended spectrum cephalosporin resistant Klebsiella pneumonia, continue Abx as per ID,  Initially cefepime and Flagyl and then switched to vancomycin meropenem which is completed.   sodium was 152 and improved, creatinine 2.4 and improved, and nephrology is consulted and appreciate recommendation. Electrolytes are replaced. Foley was placed initially for I/O but patient failed voiding trial and need to reinsert foley. Patient need to follow in urology clinic.   Imagings CXR- Patch like areas of opacification in the mid and lower lungs may be infectious/inflammatory in etiology.  Aspiration could be considered,  V/Q scan- Low probability for pulmonary embolus.   CT chest- Extensive changes of multifocal atypical pneumonia most confluent at the left greater than right lower lobes, with all lobes involved.Severe appearing changes of coronary artery disease are present.   CT abd Suspected colitis most likely infectious. Foley catheter is seen within the urinary bladder which is collapsed and thick-walled. Duplex no DVT, renal US- no acute changes Echo- Stage 1: 1: Multiple segmental abnormalities exist. See findings. Definity contrast agent was given IV to delineate the left ventricular endocardial borders. Discharged on 7/20/22
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Coronary artery disease, Culture, Echocardiogram abnormal
Clinical narrative: Patient received pfizer vaccine on 8/24/21 and 9/22/21. COVID positive on 7/1/22. PResented to ER on 7/7/22. COVID test + about 7 days ago and was treated with Paxlovid and 2 L of oxygen and dexamethasone at NH. He went to Hospital ED because his respiratory status get worse with hypoxia and then required intubation. He was also found to be hypotensive and required pressor therapy.  He was then transferred for further care. patient's diagnosed and admitted as septic shock with acute hypoxic respiratory failure with COVID-19 pneumonia, hypernatremia, AKI, elevated transaminitis, Troponin. ICU, cardiologist, nephrologist, id is consulted. Patient received amiodarone drip for non sustained V-tach and then switched to oral Amiodarone. TTE showed stage 1 multiple segmental abnormalities.  No mention of EF and no pericardial effusion. Cardiologist requested records to see if findings are new.  Pt previously on meds for heart failure.  No further ischemic workup pursued given pt's comorbidities and acute illness. Pt to f/u with Cardiologist as OP and ischemic workup can be considered.  Initially patient require Levophed for septic shock, blood pressure is improved and levophed is off since 7/7/22 overnight    COVID 19 +,  WBC 23, Elevated inflammatory markers- D-dimer > 20, AST 680, ALT 496, troponin 557, BNP 460, C-reactive protein 200, procalcitonin 84, Inflammatory markers are improved.  patient was treated with cefepime, Flagyl, Decadron, Hydrocort, Remdesivir. oxygen saturation was improved and then patient is extubated on  07/11/2022,    MRSA nasal +. respiratory culture- MRSA, extended spectrum cephalosporin resistant Klebsiella pneumonia, continue Abx as per ID,  Initially cefepime and Flagyl and then switched to vancomycin meropenem which is completed.   sodium was 152 and improved, creatinine 2.4 and improved, and nephrology is consulted and appreciate recommendation. Electrolytes are replaced. Foley was placed initially for I/O but patient failed voiding trial and need to reinsert foley. Patient need to follow in urology clinic.   Imagings CXR- Patch like areas of opacification in the mid and lower lungs may be infectious/inflammatory in etiology.  Aspiration could be considered,  V/Q scan- Low probability for pulmonary embolus.   CT chest- Extensive changes of multifocal atypical pneumonia most confluent at the left greater than right lower lobes, with all lobes involved.Severe appearing changes of coronary artery disease are present.   CT abd Suspected colitis most likely infectious. Foley catheter is seen within the urinary bladder which is collapsed and thick-walled. Duplex no DVT, renal US- no acute changes Echo- Stage 1: 1: Multiple segmental abnormalities exist. See findings. Definity contrast agent was given IV to delineate the left ventricular endocardial borders. Discharged on 7/20/22
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Electrolyte substitution therapy, Endotracheal intubation, Fibrin D dimer, Hypernatraemia, Hypertransaminasaemia
Clinical narrative: Patient received pfizer vaccine on 8/24/21 and 9/22/21. COVID positive on 7/1/22. PResented to ER on 7/7/22. COVID test + about 7 days ago and was treated with Paxlovid and 2 L of oxygen and dexamethasone at NH. He went to Hospital ED because his respiratory status get worse with hypoxia and then required intubation. He was also found to be hypotensive and required pressor therapy.  He was then transferred for further care. patient's diagnosed and admitted as septic shock with acute hypoxic respiratory failure with COVID-19 pneumonia, hypernatremia, AKI, elevated transaminitis, Troponin. ICU, cardiologist, nephrologist, id is consulted. Patient received amiodarone drip for non sustained V-tach and then switched to oral Amiodarone. TTE showed stage 1 multiple segmental abnormalities.  No mention of EF and no pericardial effusion. Cardiologist requested records to see if findings are new.  Pt previously on meds for heart failure.  No further ischemic workup pursued given pt's comorbidities and acute illness. Pt to f/u with Cardiologist as OP and ischemic workup can be considered.  Initially patient require Levophed for septic shock, blood pressure is improved and levophed is off since 7/7/22 overnight    COVID 19 +,  WBC 23, Elevated inflammatory markers- D-dimer > 20, AST 680, ALT 496, troponin 557, BNP 460, C-reactive protein 200, procalcitonin 84, Inflammatory markers are improved.  patient was treated with cefepime, Flagyl, Decadron, Hydrocort, Remdesivir. oxygen saturation was improved and then patient is extubated on  07/11/2022,    MRSA nasal +. respiratory culture- MRSA, extended spectrum cephalosporin resistant Klebsiella pneumonia, continue Abx as per ID,  Initially cefepime and Flagyl and then switched to vancomycin meropenem which is completed.   sodium was 152 and improved, creatinine 2.4 and improved, and nephrology is consulted and appreciate recommendation. Electrolytes are replaced. Foley was placed initially for I/O but patient failed voiding trial and need to reinsert foley. Patient need to follow in urology clinic.   Imagings CXR- Patch like areas of opacification in the mid and lower lungs may be infectious/inflammatory in etiology.  Aspiration could be considered,  V/Q scan- Low probability for pulmonary embolus.   CT chest- Extensive changes of multifocal atypical pneumonia most confluent at the left greater than right lower lobes, with all lobes involved.Severe appearing changes of coronary artery disease are present.   CT abd Suspected colitis most likely infectious. Foley catheter is seen within the urinary bladder which is collapsed and thick-walled. Duplex no DVT, renal US- no acute changes Echo- Stage 1: 1: Multiple segmental abnormalities exist. See findings. Definity contrast agent was given IV to delineate the left ventricular endocardial borders. Discharged on 7/20/22
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Hypoxia, Illness, Inappropriate schedule of product administration, Inflammatory marker increased
Clinical narrative: Patient received pfizer vaccine on 8/24/21 and 9/22/21. COVID positive on 7/1/22. PResented to ER on 7/7/22. COVID test + about 7 days ago and was treated with Paxlovid and 2 L of oxygen and dexamethasone at NH. He went to Hospital ED because his respiratory status get worse with hypoxia and then required intubation. He was also found to be hypotensive and required pressor therapy.  He was then transferred for further care. patient's diagnosed and admitted as septic shock with acute hypoxic respiratory failure with COVID-19 pneumonia, hypernatremia, AKI, elevated transaminitis, Troponin. ICU, cardiologist, nephrologist, id is consulted. Patient received amiodarone drip for non sustained V-tach and then switched to oral Amiodarone. TTE showed stage 1 multiple segmental abnormalities.  No mention of EF and no pericardial effusion. Cardiologist requested records to see if findings are new.  Pt previously on meds for heart failure.  No further ischemic workup pursued given pt's comorbidities and acute illness. Pt to f/u with Cardiologist as OP and ischemic workup can be considered.  Initially patient require Levophed for septic shock, blood pressure is improved and levophed is off since 7/7/22 overnight    COVID 19 +,  WBC 23, Elevated inflammatory markers- D-dimer > 20, AST 680, ALT 496, troponin 557, BNP 460, C-reactive protein 200, procalcitonin 84, Inflammatory markers are improved.  patient was treated with cefepime, Flagyl, Decadron, Hydrocort, Remdesivir. oxygen saturation was improved and then patient is extubated on  07/11/2022,    MRSA nasal +. respiratory culture- MRSA, extended spectrum cephalosporin resistant Klebsiella pneumonia, continue Abx as per ID,  Initially cefepime and Flagyl and then switched to vancomycin meropenem which is completed.   sodium was 152 and improved, creatinine 2.4 and improved, and nephrology is consulted and appreciate recommendation. Electrolytes are replaced. Foley was placed initially for I/O but patient failed voiding trial and need to reinsert foley. Patient need to follow in urology clinic.   Imagings CXR- Patch like areas of opacification in the mid and lower lungs may be infectious/inflammatory in etiology.  Aspiration could be considered,  V/Q scan- Low probability for pulmonary embolus.   CT chest- Extensive changes of multifocal atypical pneumonia most confluent at the left greater than right lower lobes, with all lobes involved.Severe appearing changes of coronary artery disease are present.   CT abd Suspected colitis most likely infectious. Foley catheter is seen within the urinary bladder which is collapsed and thick-walled. Duplex no DVT, renal US- no acute changes Echo- Stage 1: 1: Multiple segmental abnormalities exist. See findings. Definity contrast agent was given IV to delineate the left ventricular endocardial borders. Discharged on 7/20/22
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Klebsiella test, Large intestine infection, Lung opacity, Oxygen saturation abnormal
Clinical narrative: Patient received pfizer vaccine on 8/24/21 and 9/22/21. COVID positive on 7/1/22. PResented to ER on 7/7/22. COVID test + about 7 days ago and was treated with Paxlovid and 2 L of oxygen and dexamethasone at NH. He went to Hospital ED because his respiratory status get worse with hypoxia and then required intubation. He was also found to be hypotensive and required pressor therapy.  He was then transferred for further care. patient's diagnosed and admitted as septic shock with acute hypoxic respiratory failure with COVID-19 pneumonia, hypernatremia, AKI, elevated transaminitis, Troponin. ICU, cardiologist, nephrologist, id is consulted. Patient received amiodarone drip for non sustained V-tach and then switched to oral Amiodarone. TTE showed stage 1 multiple segmental abnormalities.  No mention of EF and no pericardial effusion. Cardiologist requested records to see if findings are new.  Pt previously on meds for heart failure.  No further ischemic workup pursued given pt's comorbidities and acute illness. Pt to f/u with Cardiologist as OP and ischemic workup can be considered.  Initially patient require Levophed for septic shock, blood pressure is improved and levophed is off since 7/7/22 overnight    COVID 19 +,  WBC 23, Elevated inflammatory markers- D-dimer > 20, AST 680, ALT 496, troponin 557, BNP 460, C-reactive protein 200, procalcitonin 84, Inflammatory markers are improved.  patient was treated with cefepime, Flagyl, Decadron, Hydrocort, Remdesivir. oxygen saturation was improved and then patient is extubated on  07/11/2022,    MRSA nasal +. respiratory culture- MRSA, extended spectrum cephalosporin resistant Klebsiella pneumonia, continue Abx as per ID,  Initially cefepime and Flagyl and then switched to vancomycin meropenem which is completed.   sodium was 152 and improved, creatinine 2.4 and improved, and nephrology is consulted and appreciate recommendation. Electrolytes are replaced. Foley was placed initially for I/O but patient failed voiding trial and need to reinsert foley. Patient need to follow in urology clinic.   Imagings CXR- Patch like areas of opacification in the mid and lower lungs may be infectious/inflammatory in etiology.  Aspiration could be considered,  V/Q scan- Low probability for pulmonary embolus.   CT chest- Extensive changes of multifocal atypical pneumonia most confluent at the left greater than right lower lobes, with all lobes involved.Severe appearing changes of coronary artery disease are present.   CT abd Suspected colitis most likely infectious. Foley catheter is seen within the urinary bladder which is collapsed and thick-walled. Duplex no DVT, renal US- no acute changes Echo- Stage 1: 1: Multiple segmental abnormalities exist. See findings. Definity contrast agent was given IV to delineate the left ventricular endocardial borders. Discharged on 7/20/22